Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Treasury Shares (2019 - 2025)

Cyclerion Therapeutics (CYCN) has disclosed Treasury Shares for 7 consecutive years, with $119102.0 as the latest value for Q3 2025.

  • For Q3 2025, Treasury Shares fell 33.54% year-over-year to $119102.0; the TTM value through Sep 2025 reached $119102.0, down 33.54%, while the annual FY2024 figure was $164174.0, 3.96% down from the prior year.
  • Treasury Shares hit $119102.0 in Q3 2025 for Cyclerion Therapeutics, down from $134126.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $809417.0 in Q1 2023 and bottomed at $34362.0 in Q2 2023.
  • Average Treasury Shares over 5 years is $159839.0, with a median of $134126.0 recorded in 2025.
  • Year-over-year, Treasury Shares crashed 74.6% in 2022 and then soared 465.22% in 2024.
  • Cyclerion Therapeutics' Treasury Shares stood at $92804.0 in 2021, then tumbled by 56.07% to $40772.0 in 2022, then surged by 319.25% to $170937.0 in 2023, then dropped by 3.96% to $164174.0 in 2024, then fell by 27.45% to $119102.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $119102.0, $134126.0, and $149150.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.